Home » News

γ-Cyclodextrin

These are related to the γ-Cyclodextrin news, in which you can learn about the updated information in γ-Cyclodextrin, to help you better understand and expand γ-Cyclodextrin market. Because the market for γ-Cyclodextrin is evolving and changing, so we recommend that you collect our website, and we will show you the latest news on a regular basis.
  • Going big with δ-cyclodextrin
    Going big with δ-cyclodextrin
    2025-05-22
    Going big with δ-cyclodextrin The first scaled-up synthesis of this 9-sugar ring could expand its applications Chemists have a sweet spot for cyclodextrin (CD) rings, cyclic molecules made of glucose sugars linked together like dancers in a Henri Matisse painting. Cyclodextrins have found use as drug delivery agents that encapsulate active pharmaceutical ingredients, as air fresheners that soak up stinky compounds, and as water purification systems that capture and destroy pollutants. Each year, chemical makers churn out thousands of metric tons of the most common ones: six-, seven-, and eight-sugar rings, known as α-, β-, and γ-CD, respectively.
    Read More
  • Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
    Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
    2024-09-05
    Despite a patent extension, Merck’s muscle relaxant reversal injection is now facing potential generic competition from Hikma Pharmaceuticals, which is seeking the FDA’s approval for a copycat version. Merck in an SEC filing disclosed on Monday that Hikma Pharmaceuticals U.S. is seeking the FDA’s approval for its generic version of the muscle relaxant reversal injection Bridion (sugammadex) prior to the drug’s patent expiration. Hikma notified Merck of its intention on Feb. 5, 2024, according to the SEC filing. The British pharma is making its regulatory request under the Hatch-Waxman Act—also known as the Drug Price Competition and Patent Term Restoration Act of 1984—which established the approval pathway for generics.
    Read More
  • L-cyclodextrins synthesized in the lab for the first time
    L-cyclodextrins synthesized in the lab for the first time
    2024-04-11
    L-cyclodextrins synthesized in the lab for the first time A team of chemists at Northwestern University has successfully synthesized three L-cyclodextrins in the lab for the first time. In their study, published in the journal Nature Synthesis, the group used a one-pot strategy to achieve the feat.
    Read More
  • Molecular light switch speeds up tricky cyclodextrin synthesis
    Molecular light switch speeds up tricky cyclodextrin synthesis
    2023-11-02
    Molecular light switch speeds up tricky cyclodextrin synthesis Because it is so difficult to make, γ-cyclodextrin is about 10 times more expensive than the six-glucose α-cyclodextrin A light-activated molecular switch could drive down the cost of a useful, but difficult to make γ-cyclodextrin.
    Read More
  • Taking the steam out of γ-cyclodextrin synthesis
    Taking the steam out of γ-cyclodextrin synthesis
    2023-10-19
    What to know about horse chestnut Horse chestnut is a tree that produces spiny-shelled fruits containing seeds, known as conkers. These may have some health benefits, for instance in treating varicose veins and hemorrhoids. However, they may also have adverse effects.
    Read More
Phone:
+86-21-69895597
Address:
Rm 327,3rd Floor D Zone,No.33,Lianxin Rd.,Liantang Town,Qingpu Dist.Shanghai China
About Us
Tocosynth is the Chinese dosmetic susidiary company of Tocopharm,who mainly R&D and manufacturing chemicals raw materials based in Shanghai,China.Our company was established in 2012.
Subscribe
Sign up for our newsletter to receive the latest news.


Copryright © 2023 Tocopharm(Shanghai) Co., Ltd. Technology by Leadong.Sitemap